NCT06381050 The Clinical Study of SHR-7631 for Injection in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT06376136 A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06370013 Rollover Study to Provide Continued Access to TT-00420 (Tinengotinib) for Subjects With Advanced Solid Tumors Status AVAILABLE Phase N/A
NCT06368960 BM201 in Combination With Radiotherapy in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06341114 A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06336707 HS-20089 Combination Treatment in Subjects With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06331559 Study of SIM0501 Alone and in Combination in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT06329206 A Phase Ia/Ib Study of GH2616 Tablet in Subjects With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06314373 A Study for HSK39775 in Participants With Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06242691 Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors (MK-1200-002) Status COMPLETED Phase PHASE1/PHASE2
NCT06239467 First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer Status RECRUITING Phase PHASE1
NCT06239155 A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06238401 An Open-label, Multi-center, Dose-escalation and Cohort Expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Efficacy of ACR246 in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06235983 A Study of LY3537982 in Chinese Participants With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06235541 A First-in-human Study of GENA-104A16 in Patients With Advanced Solid Tumors Status WITHDRAWN Phase PHASE1
NCT06224855 A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies Status RECRUITING Phase PHASE1
NCT06214143 A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2